This medication is a type of targeted therapy called an isocitrate dehydrogenase-1 (IDH1) inhibitor. Ivosidenib works by targeting and blocking IDH 1 enzyme. In some cancers, this receptor is overactive, causing cells to grow and divide too fast. By inhibiting these, this medication can slow or stop tumor growth.
Is Ivosidenib a chemotherapy drug?
Ivosidenib (Tibsovo) - Chemotherapy Drug Information | Chemocare.
How is Ivosidenib administered?
The recommended dose of TIBSOVO is 500 mg taken orally once daily until disease progression or unacceptable toxicity. For patients without disease progression or unacceptable toxicity, treat for a minimum of 6 months to allow time for clinical response. Administer TIBSOVO with or without food.
Is Tibsovo chemotherapy?
Is Tibsovo chemotherapy? Tibsovo is used to treat a type of cancer called acute myeloid leukemia (AML). However, it's not a chemotherapy drug.
Is Vyxeos chemo?
Vyxeos is a fixed-combination of chemotherapy drugs daunorubicin and cytarabine.Aug 3, 2017
How long can you take Tibsovo?
Recommended Dosage The recommended dose of TIBSOVO is 500 mg taken orally once daily until disease progression or unacceptable toxicity. For patients without disease progression or unacceptable toxicity, treat for a minimum of 6 months to allow time for clinical response.
What is Tibsovo?
TIBSOVO is a prescription medicine used to treat: acute myeloid leukemia (AML) with an isocitrate dehydrogenase-1 (IDH1) mutation in: adults with newly diagnosed AML who are 75 years or older or who have health problems that prevent the use of certain chemotherapy treatments.
What are the side effects of Tibsovo?
- Fever.
- Cough.
- Trouble breathing.
- Rash.
- Decreased. urination.
- Dizziness or lightheadedness.
- Rapid. weight gain.
- Swelling of your. arms or legs.
Who manufactures Ivosidenib?
Ivosidenib is an orally available small molecule inhibitor of mutated cytosolic isocitrate dehydrogenase 1 (IDH1m inhibitor), being developed by Servier for the treatment of cancer in patients with IDH1 mutations.
Which drug is approved by the FDA?
Approval Date Drug Name Submission
------------- -------------------------------- ----------
01/03/2022 SPRAVATO NDA #211243 SUPPL-6
01/03/2022 FENOFIBRIC ACID ANDA #212562 SUPPL-1
01/03/2022 PIRFENIDONE ANDA #212569 ORIG-1
01/03/2022 DOXYCYCLINE HYCLATE ANDA #213075 ORIG-1